Basic Information
| Drug ID | DDPD04908 |
|
| Drug Name | Flibanserin | |
| Molecular Weight | 390.4021 | |
| Molecular Formula | C20H21F3N4O | |
| CAS Number | 167933-07-5 | |
| SMILES | FC(F)(F)C1=CC(=CC=C1)N1CCN(CCN2C(=O)NC3=CC=CC=C23)CC1 | |
| External Links | ||
| DRUGBANK | DB04908 | |
| PubChem Compound | 6918248 | |
| PDR | 3791 | |
| Drugs.com | Drugs.com Drug Page | |
Experimental Physicochemical Property
Not Available
Pharmacokinetic/ Toxicokinetic Property
| Property Name | Property Value | Unit | Raw Value | Raw Unit | Annotation | Reference |
|---|---|---|---|---|---|---|
| Bioavailability | 33.0 | % | 33 | % | PO, oral; | DRUGBANK |
| Half-life | 11.0 | h | ~11 | h | DRUGBANK | |
| Eliminate Route | 51.0 | % | 51 | % | Faeces excretion; Oral single dose; | DRUGBANK | Eliminate Route | 44.0 | % | 44 | % | Urinary excretion; PO, oral; | DRUGBANK |
| Protein Binding | 98.0 | % | ~98 | % | DRUGBANK |
Maximum Dosage
| Property Name | Property Value | Unit | Raw Value | Raw Unit | Annotation | Brand Name | Component | Reference |
|---|---|---|---|---|---|---|---|---|
| Max dose for adults | 100.0 | mg/day | 100 | mg/day | PO, oral | Addyi | flibanserin | PDR |
Drug Property Radar Chart
Note: Center: Q1-1.5*IQR, Edge: Q3+1.5*IQR; Q1: Quantile 1, Q3: Quantile 3, IQR: Q3-Q1